YOLO vs. OZEM ETF Comparison

Comparison of AdvisorShares Pure Cannabis ETF (YOLO) to Roundhill GLP-1 & Weight Loss ETF (OZEM)
YOLO

AdvisorShares Pure Cannabis ETF

YOLO Description

Cannabis and its various applications have been used throughout human civilization for over 5,000 years. As society, business and regulatory landscapes evolve in the 21st century, the upside potential of cannabis as an emerging investment avenue has arrived. The portfolio manager believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities. The AdvisorShares Pure Cannabis ETF (Ticker: YOLO) became the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. The AdvisorShares Pure Cannabis ETF, or YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace.

Grade (RS Rating)

Last Trade

$2.59

Average Daily Volume

56,420

Number of Holdings *

9

* may have additional holdings in another (foreign) market
OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$25.29

Average Daily Volume

37,622

Number of Holdings *

14

* may have additional holdings in another (foreign) market
Performance
Period YOLO OZEM
30 Days -26.21% -10.60%
60 Days -19.80% -11.17%
90 Days -22.41% -12.25%
12 Months -9.71%
0 Overlapping Holdings
Symbol Grade Weight in YOLO Weight in OZEM Overlap
YOLO Overweight 9 Positions Relative to OZEM
Symbol Grade Weight
MSOS F 35.08%
HITI B 11.58%
SNDL D 7.02%
REFI A 4.06%
JAZZ B 3.63%
OGI F 3.38%
AFCG D 3.33%
TLRY F 2.28%
INM B 0.62%
YOLO Underweight 14 Positions Relative to OZEM
Symbol Grade Weight
NVO F -17.04%
LLY F -14.13%
ALT C -4.44%
AZN F -3.99%
VKTX F -3.39%
AMGN F -3.26%
PFE F -3.07%
SRRK C -2.8%
REGN F -2.4%
RYTM C -2.3%
TAK D -2.17%
TERN F -1.97%
CORT B -1.77%
OPK C -1.72%
Compare ETFs